Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene
9.5 Other GSH-responsive therapeutic strategies Modalities GSH-activated nanomedicines were also developed for other therapies, including photothermal therapy
Obsessive-compulsive disorder (OCD): An RCT in 48 patients found that NAC (2,400 mg/day) as an add-on to fluvoxamine significantly improved Yale-Brown OCD Scale scores compared to placebo over 12 weeks (Afshar et al., J Clin Psychopharmacol, 2012) [72]
Antioxid Redox Signal 29(17):17271745 Tserga E, Nandwani T, Edvall NK, Bulla J, Patel P, Canlon B, Cederroth CR, Baguley DM (2019) The genetic vulnerability to cisplatin ototoxicity: a systematic review
[Updated 2024 May 29]
2025 Lavender Sky Health This tool is for informational purposes only
